![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Alzheimer's and dementia: What's the difference? - Mayo Clinic
Mar 13, 2024 · While dementia is a general term, Alzheimer's disease is a specific brain disease. It is marked by symptoms of dementia that gradually get worse over time. Alzheimer's disease …
Alzheimer's disease - Symptoms and causes - Mayo Clinic
Nov 8, 2024 · Alzheimer's disease is the most common cause of dementia. Alzheimer's disease is the biological process that begins with the appearance of a buildup of proteins in the form of …
Alzheimer's disease - Diagnosis and treatment - Mayo Clinic
Nov 8, 2024 · They also can check for proteins in the brain that are linked to Alzheimer's disease. The tests may help your healthcare team better identify the disease causing dementia …
Alzheimer's stages: How the disease progresses - Mayo Clinic
Jun 7, 2023 · Mild dementia due to Alzheimer's disease. Moderate dementia due to Alzheimer's disease. Severe dementia due to Alzheimer's disease. Dementia is a term used to describe a …
Dementia - Symptoms and causes - Mayo Clinic
Mixed dementia. Autopsy studies of the brains of people age 80 and older who had dementia indicate that many had a combination of several causes. People with mixed dementia can …
Dementia - Diagnosis and treatment - Mayo Clinic
After being diagnosed with dementia, you'll need to consider many details to prepare you and your family members to deal with the condition. Care and support for the person with the …
Alzheimer's prevention: Does it exist? - Mayo Clinic
Sep 25, 2024 · But there's strong evidence that healthy lifestyle habits — such as diet, exercise and not smoking — may play a role in reducing your risk of Alzheimer's disease and other …
Diagnosing Alzheimer's: How Alzheimer's is diagnosed
Mar 13, 2024 · New tests might be able to diagnose the disease when symptoms are very mild or even before symptoms start. Currently, researchers are developing tests that measure amyloid …
Alzheimer's treatments: What's on the horizon? - Mayo Clinic
Jul 10, 2024 · The U.S. Food and Drug Administration (FDA) has approved lecanemab (Leqembi) and donanemab (Kisunla) for people with mild Alzheimer's disease and mild cognitive …
Young-onset Alzheimer's: When symptoms begin before age 65
Apr 10, 2024 · Young-onset Alzheimer's disease is an uncommon form of dementia that affects people younger than age 65. The condition also is called early-onset Alzheimer's disease. …